Carregant...
A new niclosamide derivatives‐B17 can inhibit urological cancers growth through apoptosis‐related pathway
The incidence and mortality rate of urological cancers is increasing yearly. Niclosamide has been repurposed as an anti‐cancer drug in recent years. Synthesized derivative of niclosamide was testified for its anti‐cancer activity in urological cancers. MTT assay was used to measure the cytotoxicity...
Guardat en:
| Publicat a: | Cancer Med |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6089145/ https://ncbi.nlm.nih.gov/pubmed/29953738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1635 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|